drugset / Trial / NCT02309671

A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment

NCT02309671 ↗

Phase 2 Completed 159 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

This trial investigates the effects of several doses of FE 999049 in Japanese women undergoing IVF/ICSI treatment.

Timeline

Start
2014-12
Primary completion
2015-11
Completion
2016-09

Outcome

Met primary endpoint

paper and a significant dose-relation was established PMID 33272623 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Follitropin beta Protein / enzyme biologic 150 iu —
Subject Follitropin delta Protein / enzyme biologic 6 ug —
Subject Follitropin delta Protein / enzyme biologic 9 ug —
Subject Follitropin delta Protein / enzyme biologic 12 ug —

Indications